I agree that this site is using cookies. You can find further informations here.
X
Hoisnard, Léa
26  results:
Search for persons X
?
1

Persistence and safety of anti-TNF biosimilars versus origi..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
RMD Open.  10 (2024)  1 - p. e003531 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Risk of Gastrointestinal Perforation in Patients With Rheum..:

Hoisnard, Lea ; Meyer, Antoine ; Dray‐Spira, Rosemary...
Arthritis & Rheumatology.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Validation of an Algorithm to Identify Epidermal Necrolysis..:

Bettuzzi, Thomas ; Hoisnard, Léa ; Beytout, Quentin..
Journal of Investigative Dermatology.  144 (2024)  3 - p. 708-710.e7 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Prolonged use of nomegestrol acetate and risk of intracrani..:

Nguyen, Pierre ; Roland, Noémie ; Neumann, Anke...
The Lancet Regional Health - Europe.  42 (2024)  - p. 100928 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Use of progestogens and the risk of intracranial meningioma..:

Roland, Noémie ; Neumann, Anke ; Hoisnard, Léa...
BMJ.  , 2024
Link: https://doi.org/10.1136/..
 
?
6

Severe Hypersensitivity Reactions at Biosimilar versus Orig..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
BioDrugs.  37 (2023)  3 - p. 397-407 , 2023
Link: https://doi.org/10.1007/..
 
?
7

32696 Adverse events associated with JAK inhibitors in 126,..:

Hoisnard, Lea ; Maury, Pr Sébastien ; Mahévas, Pr Matthieu...
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB137 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Adverse events associated with JAK inhibitors in 126,815 re..:

Hoisnard, Léa ; Lebrun-Vignes, Bénédicte ; Maury, Sébastien...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
9

Three-Year Outcomes in Kidney Transplant Recipients Switche..:

Morel, Antoine ; Hoisnard, Léa ; Dudreuilh, Caroline...
Transplant International.  35 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

TNF-alpha inhibitors biosimilar use in France: a nationwide..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Risk of intracranial meningioma with three potent progestog..:

Hoisnard, Léa ; Laanani, Moussa ; Passeri, Thibault...
European Journal of Neurology.  29 (2022)  9 - p. 2801-2809 , 2022
Link: https://doi.org/10.1111/..
 
?
12

Long-term persistence of second-line biologics in psoriatic..:

Pina Vegas, Laura ; Hoisnard, Léa ; Bastard, Léa..
RMD Open.  8 (2022)  2 - p. e002681 , 2022
Link: https://doi.org/10.1136/..
 
?
13

Do older adults know the purpose of their medications? A su..:

Hoisnard, Léa ; Santos-Eggimann, Brigitte ; Chauvin, Pauline..
European Journal of Clinical Pharmacology.  75 (2018)  2 - p. 255-263 , 2018
Link: https://doi.org/10.1007/..
 
?
14

TNF-alpha inhibitors biosimilar use in France: a nationwide..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7.  , 2022
Link: https://hal.u-pec.fr/hal..
 
?
15

Three-Year Outcomes in Kidney Transplant Recipients Switche..:

Morel, Antoine ; Hoisnard, Léa ; Dudreuilh, Caroline...
info:eu-repo/semantics/altIdentifier/doi/10.3389/ti.2022.10228.  , 2022
Link: https://hal.u-pec.fr/hal..
 
1-15